Notably, although Hsp90 inhibitor NXD30001 has shown effective effects in enhancing radiosensitivity of GBM by targeting multiple radio-resistant pathways in our study, it is premature to conclude that the combination of NXD30001 and radiotherapy is a promising candidate to enhance GBM treatment. Here, HSP90AB1 is linked to glioblastoma.